Stay updated on China CKD Study of FG-4592 Clinical Trial
Sign up to get notified when there's something new on the China CKD Study of FG-4592 Clinical Trial page.

Latest updates to the China CKD Study of FG-4592 Clinical Trial page
- ChecktodayChange DetectedThe web page has added significant content related to drug safety, including specific mentions of roxadustat and counterfeit drugs, while also updating the facility name and location to Dalian, China. Several previous entries related to various diseases and locations have been removed.SummaryDifference4%
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12, indicating a revision in the content.SummaryDifference0.1%
- Check22 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check29 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference2%
- Check36 days agoChange DetectedThe web page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and it now includes information about HHS Vulnerability Disclosure.SummaryDifference0.3%
- Check43 days agoChange DetectedThe web page has been updated from version 2.16.5 to version 2.16.6.SummaryDifference0.1%
Stay in the know with updates to China CKD Study of FG-4592 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the China CKD Study of FG-4592 Clinical Trial page.